Global Stem Cell Banking

Stem Cell Banking Comprehensive Study by Type (Umbilical Cord Blood Stem Cell, Embryonic Stem Cell, Adult Stem Cell, Others), Application (Personalized Banking Applications, Research Applications {Disease Treatment Studies, Life Science Research, Drug Discovery}, Clinical Applications {HematopOIEtic Disorders, Autoimmune Disorders, Other Diseases}), Service (Sample Preservation and Storage, Sample Analysis, Sample Processing, Sample Collection and Transportation), Source (Placental Stem Cells (PSCs), Human Embryo-derived Stem Cells (hESCs), Bone Marrow-derived Stem Cells (BMSCs), Adipose Tissue-derived Stem Cells (ADSCs), Dental Pulp-derived Stem Cells (DPSCs), Other Stem Cell Sources) Players and Region - Global Market Outlook to 2030

Stem Cell Banking Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 20.5%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Stem Cell Banking Market Scope
Stem cell banking is the extraction, processing, and storage of stem cells, so that they may be used for treatment in the future when required. Stem Cells have the amazing power to transform into any tissue or organ in the human body. Stem cells have a unique characteristic & the potential to treat over 80 life-threatening diseases and offers numerous benefits to the baby, its siblings and the family. Furthermore, it is being extensively used in personalized banking, research, and clinical applications.

According to AMA, the Global Stem Cell Banking market is expected to see growth rate of 20.5%

Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Stem Cell Banking market throughout the predicted period.

Cord Blood Registry Systems (United States), Cordlife (Singapore), Cryo-Cell International (United States), Cryo-Save AG (A Subsidiary of Esperite N.V) (Netherlands), LifeCell International (India), StemCyte (United States), ViaCord (A Subsidiary of Perkinelmer) (United States), Global Cord Blood (China), Smart Cells International Ltd. (United Kingdom) and Vita 34 International (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are CryoHoldco (Mexico), Korea Stem Cell Bank Co., Ltd. (South Korea) and UK Stem Cell Bank (United Kingdom).

Segmentation Overview
The study have segmented the market of Global Stem Cell Banking market by Type (Umbilical Cord Blood Stem Cell, Embryonic Stem Cell, Adult Stem Cell and Others), by Application (Personalized Banking Applications, Research Applications {Disease Treatment Studies, Life Science Research, Drug Discovery} and Clinical Applications {HematopOIEtic Disorders, Autoimmune Disorders, Other Diseases}) and Region with country level break-up.

On the basis of geography, the market of Stem Cell Banking has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Rapid Advancements in Biotechnology Field

Market Growth Drivers:
Growing Awareness of the Therapeutic Potential of Stem Cells, Development of Novel Technologies for Stem Cell Preservation, Processing, and Storage, Increase in HematopOIEtic Stem Cell Transplantation Procedures and Increasing Investments in Stem Cell-Based Research

Challenges:
Socio-Ethical Concerns Related to Embryonic Stem Cells

Restraints:
High Operational Costs of Stem Cell Banking and Stringent Regulatory Frameworks

Opportunities:
Emerging Countries and Rising Global Burden of Major Diseases

Market Leaders and their Expansionary Development Strategies
On 4 June 2018, Cryo-Cell International, Inc., has announced an agreement to acquire substantially all of the assets of Cord:Use Cord Blood Bank, Inc. for a purchase price of 14 Million USD. The acquisition will boost Cryo-Cell International into the public cord blood banking business and is expected to further solidify Cryo-Cell International’s role as the industry leader.
On 21 Nov. 2018, LifeCell, India's premier stem cell bank, has launched their new campaign on television to create awareness and promote umbilical cord stem cell banking for the benefit and protection of the entire family.


Key Target Audience
Private, public, and community stem cell banks, tissue banks, and biobanks, Stem cell associations and organizations, Government regulatory authorities, Regenerative medicine and cellular therapy manufacturers, Pharmaceutical & biopharmaceutical product manufacturers, Healthcare service providers, Research and development (R&D) companies, Clinical research organizations (CROs) and Research laboratories and academic institutes

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Report Objectives / Segmentation Covered

By Type
  • Umbilical Cord Blood Stem Cell
  • Embryonic Stem Cell
  • Adult Stem Cell
  • Others
By Application
  • Personalized Banking Applications
  • Research Applications {Disease Treatment Studies, Life Science Research, Drug Discovery}
  • Clinical Applications {HematopOIEtic Disorders, Autoimmune Disorders, Other Diseases}
By Service
  • Sample Preservation and Storage
  • Sample Analysis
  • Sample Processing
  • Sample Collection and Transportation

By Source
  • Placental Stem Cells (PSCs)
  • Human Embryo-derived Stem Cells (hESCs)
  • Bone Marrow-derived Stem Cells (BMSCs)
  • Adipose Tissue-derived Stem Cells (ADSCs)
  • Dental Pulp-derived Stem Cells (DPSCs)
  • Other Stem Cell Sources

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Awareness of the Therapeutic Potential of Stem Cells
      • 3.2.2. Development of Novel Technologies for Stem Cell Preservation, Processing, and Storage
      • 3.2.3. Increase in HematopOIEtic Stem Cell Transplantation Procedures
      • 3.2.4. Increasing Investments in Stem Cell-Based Research
    • 3.3. Market Challenges
      • 3.3.1. Socio-Ethical Concerns Related to Embryonic Stem Cells
    • 3.4. Market Trends
      • 3.4.1. Rapid Advancements in Biotechnology Field
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Stem Cell Banking, by Type, Application, Service, Source and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Stem Cell Banking (Value)
      • 5.2.1. Global Stem Cell Banking by: Type (Value)
        • 5.2.1.1. Umbilical Cord Blood Stem Cell
        • 5.2.1.2. Embryonic Stem Cell
        • 5.2.1.3. Adult Stem Cell
        • 5.2.1.4. Others
      • 5.2.2. Global Stem Cell Banking by: Application (Value)
        • 5.2.2.1. Personalized Banking Applications
        • 5.2.2.2. Research Applications {Disease Treatment Studies, Life Science Research, Drug Discovery}
        • 5.2.2.3. Clinical Applications {HematopOIEtic Disorders, Autoimmune Disorders, Other Diseases}
      • 5.2.3. Global Stem Cell Banking by: Service (Value)
        • 5.2.3.1. Sample Preservation and Storage
        • 5.2.3.2. Sample Analysis
        • 5.2.3.3. Sample Processing
        • 5.2.3.4. Sample Collection and Transportation
      • 5.2.4. Global Stem Cell Banking by: Source (Value)
        • 5.2.4.1. Placental Stem Cells (PSCs)
        • 5.2.4.2. Human Embryo-derived Stem Cells (hESCs)
        • 5.2.4.3. Bone Marrow-derived Stem Cells (BMSCs)
        • 5.2.4.4. Adipose Tissue-derived Stem Cells (ADSCs)
        • 5.2.4.5. Dental Pulp-derived Stem Cells (DPSCs)
        • 5.2.4.6. Other Stem Cell Sources
      • 5.2.5. Global Stem Cell Banking Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Stem Cell Banking (Price)
      • 5.3.1. Global Stem Cell Banking by: Type (Price)
  • 6. Stem Cell Banking: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cord Blood Registry Systems (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cordlife (Singapore)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cryo-Cell International (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cryo-Save AG (A Subsidiary of Esperite N.V) (Netherlands)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. LifeCell International (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. StemCyte (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ViaCord (A Subsidiary of Perkinelmer) (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Global Cord Blood (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Smart Cells International Ltd. (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Vita 34 International (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Stem Cell Banking Sale, by Type, Application, Service, Source and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Stem Cell Banking (Value)
      • 7.2.1. Global Stem Cell Banking by: Type (Value)
        • 7.2.1.1. Umbilical Cord Blood Stem Cell
        • 7.2.1.2. Embryonic Stem Cell
        • 7.2.1.3. Adult Stem Cell
        • 7.2.1.4. Others
      • 7.2.2. Global Stem Cell Banking by: Application (Value)
        • 7.2.2.1. Personalized Banking Applications
        • 7.2.2.2. Research Applications {Disease Treatment Studies, Life Science Research, Drug Discovery}
        • 7.2.2.3. Clinical Applications {HematopOIEtic Disorders, Autoimmune Disorders, Other Diseases}
      • 7.2.3. Global Stem Cell Banking by: Service (Value)
        • 7.2.3.1. Sample Preservation and Storage
        • 7.2.3.2. Sample Analysis
        • 7.2.3.3. Sample Processing
        • 7.2.3.4. Sample Collection and Transportation
      • 7.2.4. Global Stem Cell Banking by: Source (Value)
        • 7.2.4.1. Placental Stem Cells (PSCs)
        • 7.2.4.2. Human Embryo-derived Stem Cells (hESCs)
        • 7.2.4.3. Bone Marrow-derived Stem Cells (BMSCs)
        • 7.2.4.4. Adipose Tissue-derived Stem Cells (ADSCs)
        • 7.2.4.5. Dental Pulp-derived Stem Cells (DPSCs)
        • 7.2.4.6. Other Stem Cell Sources
      • 7.2.5. Global Stem Cell Banking Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Stem Cell Banking (Price)
      • 7.3.1. Global Stem Cell Banking by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Stem Cell Banking: by Type(USD Million)
  • Table 2. Stem Cell Banking Umbilical Cord Blood Stem Cell , by Region USD Million (2018-2023)
  • Table 3. Stem Cell Banking Embryonic Stem Cell , by Region USD Million (2018-2023)
  • Table 4. Stem Cell Banking Adult Stem Cell , by Region USD Million (2018-2023)
  • Table 5. Stem Cell Banking Others , by Region USD Million (2018-2023)
  • Table 6. Stem Cell Banking: by Application(USD Million)
  • Table 7. Stem Cell Banking Personalized Banking Applications , by Region USD Million (2018-2023)
  • Table 8. Stem Cell Banking Research Applications {Disease Treatment Studies, Life Science Research, Drug Discovery} , by Region USD Million (2018-2023)
  • Table 9. Stem Cell Banking Clinical Applications {HematopOIEtic Disorders, Autoimmune Disorders, Other Diseases} , by Region USD Million (2018-2023)
  • Table 10. Stem Cell Banking: by Service(USD Million)
  • Table 11. Stem Cell Banking Sample Preservation and Storage , by Region USD Million (2018-2023)
  • Table 12. Stem Cell Banking Sample Analysis , by Region USD Million (2018-2023)
  • Table 13. Stem Cell Banking Sample Processing , by Region USD Million (2018-2023)
  • Table 14. Stem Cell Banking Sample Collection and Transportation , by Region USD Million (2018-2023)
  • Table 15. Stem Cell Banking: by Source(USD Million)
  • Table 16. Stem Cell Banking Placental Stem Cells (PSCs) , by Region USD Million (2018-2023)
  • Table 17. Stem Cell Banking Human Embryo-derived Stem Cells (hESCs) , by Region USD Million (2018-2023)
  • Table 18. Stem Cell Banking Bone Marrow-derived Stem Cells (BMSCs) , by Region USD Million (2018-2023)
  • Table 19. Stem Cell Banking Adipose Tissue-derived Stem Cells (ADSCs) , by Region USD Million (2018-2023)
  • Table 20. Stem Cell Banking Dental Pulp-derived Stem Cells (DPSCs) , by Region USD Million (2018-2023)
  • Table 21. Stem Cell Banking Other Stem Cell Sources , by Region USD Million (2018-2023)
  • Table 22. South America Stem Cell Banking, by Country USD Million (2018-2023)
  • Table 23. South America Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 24. South America Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 25. South America Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 26. South America Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 27. Brazil Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 28. Brazil Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 29. Brazil Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 30. Brazil Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 31. Argentina Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 32. Argentina Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 33. Argentina Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 34. Argentina Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 35. Rest of South America Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 36. Rest of South America Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 37. Rest of South America Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 38. Rest of South America Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 39. Asia Pacific Stem Cell Banking, by Country USD Million (2018-2023)
  • Table 40. Asia Pacific Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 41. Asia Pacific Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 42. Asia Pacific Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 43. Asia Pacific Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 44. China Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 45. China Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 46. China Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 47. China Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 48. Japan Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 49. Japan Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 50. Japan Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 51. Japan Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 52. India Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 53. India Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 54. India Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 55. India Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 56. South Korea Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 57. South Korea Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 58. South Korea Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 59. South Korea Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 60. Taiwan Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 61. Taiwan Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 62. Taiwan Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 63. Taiwan Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 64. Australia Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 65. Australia Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 66. Australia Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 67. Australia Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 70. Rest of Asia-Pacific Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 71. Rest of Asia-Pacific Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 72. Europe Stem Cell Banking, by Country USD Million (2018-2023)
  • Table 73. Europe Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 74. Europe Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 75. Europe Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 76. Europe Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 77. Germany Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 78. Germany Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 79. Germany Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 80. Germany Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 81. France Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 82. France Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 83. France Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 84. France Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 85. Italy Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 86. Italy Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 87. Italy Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 88. Italy Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 89. United Kingdom Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 90. United Kingdom Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 91. United Kingdom Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 92. United Kingdom Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 93. Netherlands Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 94. Netherlands Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 95. Netherlands Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 96. Netherlands Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 97. Rest of Europe Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 98. Rest of Europe Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 99. Rest of Europe Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 100. Rest of Europe Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 101. MEA Stem Cell Banking, by Country USD Million (2018-2023)
  • Table 102. MEA Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 103. MEA Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 104. MEA Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 105. MEA Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 106. Middle East Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 107. Middle East Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 108. Middle East Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 109. Middle East Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 110. Africa Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 111. Africa Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 112. Africa Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 113. Africa Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 114. North America Stem Cell Banking, by Country USD Million (2018-2023)
  • Table 115. North America Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 116. North America Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 117. North America Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 118. North America Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 119. United States Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 120. United States Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 121. United States Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 122. United States Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 123. Canada Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 124. Canada Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 125. Canada Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 126. Canada Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 127. Mexico Stem Cell Banking, by Type USD Million (2018-2023)
  • Table 128. Mexico Stem Cell Banking, by Application USD Million (2018-2023)
  • Table 129. Mexico Stem Cell Banking, by Service USD Million (2018-2023)
  • Table 130. Mexico Stem Cell Banking, by Source USD Million (2018-2023)
  • Table 131. Stem Cell Banking: by Type(USD/Units)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Stem Cell Banking: by Type(USD Million)
  • Table 143. Stem Cell Banking Umbilical Cord Blood Stem Cell , by Region USD Million (2025-2030)
  • Table 144. Stem Cell Banking Embryonic Stem Cell , by Region USD Million (2025-2030)
  • Table 145. Stem Cell Banking Adult Stem Cell , by Region USD Million (2025-2030)
  • Table 146. Stem Cell Banking Others , by Region USD Million (2025-2030)
  • Table 147. Stem Cell Banking: by Application(USD Million)
  • Table 148. Stem Cell Banking Personalized Banking Applications , by Region USD Million (2025-2030)
  • Table 149. Stem Cell Banking Research Applications {Disease Treatment Studies, Life Science Research, Drug Discovery} , by Region USD Million (2025-2030)
  • Table 150. Stem Cell Banking Clinical Applications {HematopOIEtic Disorders, Autoimmune Disorders, Other Diseases} , by Region USD Million (2025-2030)
  • Table 151. Stem Cell Banking: by Service(USD Million)
  • Table 152. Stem Cell Banking Sample Preservation and Storage , by Region USD Million (2025-2030)
  • Table 153. Stem Cell Banking Sample Analysis , by Region USD Million (2025-2030)
  • Table 154. Stem Cell Banking Sample Processing , by Region USD Million (2025-2030)
  • Table 155. Stem Cell Banking Sample Collection and Transportation , by Region USD Million (2025-2030)
  • Table 156. Stem Cell Banking: by Source(USD Million)
  • Table 157. Stem Cell Banking Placental Stem Cells (PSCs) , by Region USD Million (2025-2030)
  • Table 158. Stem Cell Banking Human Embryo-derived Stem Cells (hESCs) , by Region USD Million (2025-2030)
  • Table 159. Stem Cell Banking Bone Marrow-derived Stem Cells (BMSCs) , by Region USD Million (2025-2030)
  • Table 160. Stem Cell Banking Adipose Tissue-derived Stem Cells (ADSCs) , by Region USD Million (2025-2030)
  • Table 161. Stem Cell Banking Dental Pulp-derived Stem Cells (DPSCs) , by Region USD Million (2025-2030)
  • Table 162. Stem Cell Banking Other Stem Cell Sources , by Region USD Million (2025-2030)
  • Table 163. South America Stem Cell Banking, by Country USD Million (2025-2030)
  • Table 164. South America Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 165. South America Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 166. South America Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 167. South America Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 168. Brazil Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 169. Brazil Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 170. Brazil Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 171. Brazil Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 172. Argentina Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 173. Argentina Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 174. Argentina Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 175. Argentina Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 176. Rest of South America Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 177. Rest of South America Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 178. Rest of South America Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 179. Rest of South America Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 180. Asia Pacific Stem Cell Banking, by Country USD Million (2025-2030)
  • Table 181. Asia Pacific Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 182. Asia Pacific Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 183. Asia Pacific Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 184. Asia Pacific Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 185. China Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 186. China Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 187. China Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 188. China Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 189. Japan Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 190. Japan Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 191. Japan Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 192. Japan Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 193. India Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 194. India Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 195. India Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 196. India Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 197. South Korea Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 198. South Korea Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 199. South Korea Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 200. South Korea Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 201. Taiwan Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 202. Taiwan Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 203. Taiwan Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 204. Taiwan Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 205. Australia Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 206. Australia Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 207. Australia Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 208. Australia Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 209. Rest of Asia-Pacific Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 210. Rest of Asia-Pacific Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 211. Rest of Asia-Pacific Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 212. Rest of Asia-Pacific Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 213. Europe Stem Cell Banking, by Country USD Million (2025-2030)
  • Table 214. Europe Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 215. Europe Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 216. Europe Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 217. Europe Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 218. Germany Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 219. Germany Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 220. Germany Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 221. Germany Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 222. France Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 223. France Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 224. France Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 225. France Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 226. Italy Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 227. Italy Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 228. Italy Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 229. Italy Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 230. United Kingdom Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 231. United Kingdom Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 232. United Kingdom Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 233. United Kingdom Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 234. Netherlands Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 235. Netherlands Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 236. Netherlands Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 237. Netherlands Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 238. Rest of Europe Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 239. Rest of Europe Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 240. Rest of Europe Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 241. Rest of Europe Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 242. MEA Stem Cell Banking, by Country USD Million (2025-2030)
  • Table 243. MEA Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 244. MEA Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 245. MEA Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 246. MEA Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 247. Middle East Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 248. Middle East Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 249. Middle East Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 250. Middle East Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 251. Africa Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 252. Africa Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 253. Africa Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 254. Africa Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 255. North America Stem Cell Banking, by Country USD Million (2025-2030)
  • Table 256. North America Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 257. North America Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 258. North America Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 259. North America Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 260. United States Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 261. United States Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 262. United States Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 263. United States Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 264. Canada Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 265. Canada Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 266. Canada Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 267. Canada Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 268. Mexico Stem Cell Banking, by Type USD Million (2025-2030)
  • Table 269. Mexico Stem Cell Banking, by Application USD Million (2025-2030)
  • Table 270. Mexico Stem Cell Banking, by Service USD Million (2025-2030)
  • Table 271. Mexico Stem Cell Banking, by Source USD Million (2025-2030)
  • Table 272. Stem Cell Banking: by Type(USD/Units)
  • Table 273. Research Programs/Design for This Report
  • Table 274. Key Data Information from Secondary Sources
  • Table 275. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Stem Cell Banking: by Type USD Million (2018-2023)
  • Figure 5. Global Stem Cell Banking: by Application USD Million (2018-2023)
  • Figure 6. Global Stem Cell Banking: by Service USD Million (2018-2023)
  • Figure 7. Global Stem Cell Banking: by Source USD Million (2018-2023)
  • Figure 8. South America Stem Cell Banking Share (%), by Country
  • Figure 9. Asia Pacific Stem Cell Banking Share (%), by Country
  • Figure 10. Europe Stem Cell Banking Share (%), by Country
  • Figure 11. MEA Stem Cell Banking Share (%), by Country
  • Figure 12. North America Stem Cell Banking Share (%), by Country
  • Figure 13. Global Stem Cell Banking: by Type USD/Units (2018-2023)
  • Figure 14. Global Stem Cell Banking share by Players 2023 (%)
  • Figure 15. Global Stem Cell Banking share by Players (Top 3) 2023(%)
  • Figure 16. Global Stem Cell Banking share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Cord Blood Registry Systems (United States) Revenue, Net Income and Gross profit
  • Figure 19. Cord Blood Registry Systems (United States) Revenue: by Geography 2023
  • Figure 20. Cordlife (Singapore) Revenue, Net Income and Gross profit
  • Figure 21. Cordlife (Singapore) Revenue: by Geography 2023
  • Figure 22. Cryo-Cell International (United States) Revenue, Net Income and Gross profit
  • Figure 23. Cryo-Cell International (United States) Revenue: by Geography 2023
  • Figure 24. Cryo-Save AG (A Subsidiary of Esperite N.V) (Netherlands) Revenue, Net Income and Gross profit
  • Figure 25. Cryo-Save AG (A Subsidiary of Esperite N.V) (Netherlands) Revenue: by Geography 2023
  • Figure 26. LifeCell International (India) Revenue, Net Income and Gross profit
  • Figure 27. LifeCell International (India) Revenue: by Geography 2023
  • Figure 28. StemCyte (United States) Revenue, Net Income and Gross profit
  • Figure 29. StemCyte (United States) Revenue: by Geography 2023
  • Figure 30. ViaCord (A Subsidiary of Perkinelmer) (United States) Revenue, Net Income and Gross profit
  • Figure 31. ViaCord (A Subsidiary of Perkinelmer) (United States) Revenue: by Geography 2023
  • Figure 32. Global Cord Blood (China) Revenue, Net Income and Gross profit
  • Figure 33. Global Cord Blood (China) Revenue: by Geography 2023
  • Figure 34. Smart Cells International Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. Smart Cells International Ltd. (United Kingdom) Revenue: by Geography 2023
  • Figure 36. Vita 34 International (Germany) Revenue, Net Income and Gross profit
  • Figure 37. Vita 34 International (Germany) Revenue: by Geography 2023
  • Figure 38. Global Stem Cell Banking: by Type USD Million (2025-2030)
  • Figure 39. Global Stem Cell Banking: by Application USD Million (2025-2030)
  • Figure 40. Global Stem Cell Banking: by Service USD Million (2025-2030)
  • Figure 41. Global Stem Cell Banking: by Source USD Million (2025-2030)
  • Figure 42. South America Stem Cell Banking Share (%), by Country
  • Figure 43. Asia Pacific Stem Cell Banking Share (%), by Country
  • Figure 44. Europe Stem Cell Banking Share (%), by Country
  • Figure 45. MEA Stem Cell Banking Share (%), by Country
  • Figure 46. North America Stem Cell Banking Share (%), by Country
  • Figure 47. Global Stem Cell Banking: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Cord Blood Registry Systems (United States)
  • Cordlife (Singapore)
  • Cryo-Cell International (United States)
  • Cryo-Save AG (A Subsidiary of Esperite N.V) (Netherlands)
  • LifeCell International (India)
  • StemCyte (United States)
  • ViaCord (A Subsidiary of Perkinelmer) (United States)
  • Global Cord Blood (China)
  • Smart Cells International Ltd. (United Kingdom)
  • Vita 34 International (Germany)
Additional players considered in the study are as follows:
CryoHoldco (Mexico) , Korea Stem Cell Bank Co., Ltd. (South Korea) , UK Stem Cell Bank (United Kingdom)
Select User Access Type

Key Highlights of Report


Jul 2024 223 Pages 89 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Stem Cell Banking Quantitative research analysis
Global Stem Cell Banking Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Stem Cell Banking study can be customized to meet your requirements. The market size breakdown by type, by end-use application.
The Stem Cell Banking Market is gaining popularity and expected to see strong valuation by 2030 .
According to AMA, the Global Stem Cell Banking market is expected to see growth rate of xx%.
The Stem Cell Banking market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Stem Cell Banking Report?

Have a Query? Click Here

Other Related Reports

Hemostasis and Tissue Sealing Agents Comprehensive Study by Type (Topical Hemostats (Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Fibrin Sealants, and Topical Thrombin Products), Adhes...
$ 3750
Direct-Fed Microbials Comprehensive Study by Type (Lactic Acid Bacteria,, Bacillus subtilis, Yeast, Others), Application (Poultry, Swine, Ruminants, Aquatic Animals, Others), Form (Dry, Liquid), Dist...
$ 3450
Microscopy Comprehensive Study by Type (Microscopes (Optical Microscopes, Electron Microscopes, and Scanning Probe Microscopes), Software, Accessories), Application (Semiconductors, Life Sciences, Ma...
$ 3650
Immunochemicals Comprehensive Study by Type (Custom monoclonal antibodies, Custom polyclonal antibodies, Custom AB fragments, Catalogue antibodies, Others), Application (Healthcare, Environmental Sci...
$ 3750
Sheep Placenta Extract Comprehensive Study by Type (Sheep Placenta Extract Powders, Sheep Placenta Extract Fluids), Application (Dietary, Pharmaceutical, Cosmetics), Nature (Gluten-Free, Herbal, Hala...
$ 3450
DNA Sequencing Comprehensive Study by Type (Consumable, Instrument, Service), Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, Research, Treatme...
$ 3750